# CDT Equity Inc.: filings

CDT · Nasdaq · CIK 1896212 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cdt.md) · [Financials](/companies/cdt/financials.md) · [Filings](/companies/cdt/filings.md) · [Insiders](/companies/cdt/insiders.md)

## Reports and events: 131 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 73, 4 46, CORRESP 21, 3 20, 424B3 18, UPLOAD 15, 10-Q 14, EFFECT 13, SCHEDULE 13G 11, 425 10, SC 13G/A 9, 424B5 8, DEF 14A 8, SC 13G 8, PRE 14A 7, S-3 7, SCHEDULE 13D/A 7, SCHEDULE 13G/A 7, 8-K/A 6, 10-K 5, S-8 5, 10-Q/A 4, S-1 4, ARS 3, DEFA14A 3, NT 10-Q 3, S-1/A 3, S-4/A 3, SC 13D 3, SC 13D/A 3, 8-A12B 2, CERT 2, DRS 2, NT 10-K 2, SEC STAFF LETTER 2, 25-NSE 1, 4/A 1, POS AM 1, RW 1, RW WD 1, S-4 1, S-8 POS 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 16:58 ET | [DEF 14A](/filings/0001493152-26-048693.md) | Proxy statement, period 2026-10-27 | 0001493152-26-048693 |
| 2026-10-27 | 16:28 ET | [SCHEDULE 13D/A](/filings/0001753926-26-002007.md) | Ownership report, active investor, amended | 0001753926-26-002007 |
| 2026-10-27 | 08:15 ET | [8-K](/filings/0001493152-26-048638.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-048638 |
| 2026-10-13 | 08:00 ET | [8-K](/filings/0001493152-26-046738.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-046738 |
| 2026-09-25 | 08:15 ET | [8-K](/filings/0001493152-26-044248.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-044248 |
| 2026-09-18 | 17:15 ET | [8-K](/filings/0001493152-26-043398.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-043398 |
| 2026-09-08 | 17:30 ET | [S-1](/filings/0001493152-26-041808.md) | Registration statement | 0001493152-26-041808 |
| 2026-09-04 | 16:05 ET | [8-K](/filings/0001493152-26-041533.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-041533 |
| 2026-09-02 | 18:10 ET | [SCHEDULE 13D/A](/filings/0001753926-26-001696.md) | Ownership report, active investor, amended | 0001753926-26-001696 |
| 2026-09-01 | 16:15 ET | [8-K](/filings/0001493152-26-041016.md) | 8.01 Other events | 0001493152-26-041016 |
| 2026-09-01 | 08:00 ET | [8-K](/filings/0001493152-26-040929.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-040929 |
| 2026-08-21 | 09:27 ET | [8-K/A](/filings/0001493152-26-039588.md) | 9.01 Financial statements and exhibits | 0001493152-26-039588 |
| 2026-08-21 | 09:27 ET | [8-K/A](/filings/0001493152-26-039587.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-26-039587 |
| 2026-08-12 | 17:29 ET | [10-Q](/filings/0001493152-26-037458.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037458 |
| 2026-08-11 | 08:45 ET | [DEF 14A](/filings/0001493152-26-036998.md) | Proxy statement, period 2026-08-11 | 0001493152-26-036998 |
| 2026-08-06 | 16:30 ET | [8-K](/filings/0001493152-26-036361.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-036361 |
| 2026-08-03 | 16:15 ET | [8-K/A](/filings/0001493152-26-035831.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-26-035831 |
| 2026-07-31 | 17:26 ET | [8-K](/filings/0001493152-26-035682.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-035682 |
| 2026-07-29 | 16:30 ET | [8-K](/filings/0001493152-26-035202.md) | 3.02 Unregistered sale of equity | 0001493152-26-035202 |
| 2026-07-16 | 08:05 ET | [8-K](/filings/0001493152-26-033455.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-033455 |
| 2026-07-15 | 16:46 ET | [10-Q](/filings/0001493152-26-033380.md) | Quarterly report, period 2026-03-31 | 0001493152-26-033380 |
| 2026-07-07 | 17:20 ET | [8-K](/filings/0001493152-26-032375.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-26-032375 |
| 2026-06-29 | 16:30 ET | [8-K](/filings/0001493152-26-031093.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-031093 |
| 2026-06-23 | 18:42 ET | [SCHEDULE 13D/A](/filings/0001753926-26-001042.md) | Ownership report, active investor, amended | 0001753926-26-001042 |
| 2026-06-16 | 17:00 ET | [8-K](/filings/0001493152-26-028909.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-028909 |
| 2026-05-28 | 16:30 ET | [8-K](/filings/0001493152-26-025629.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-025629 |
| 2026-05-15 | 16:01 ET | [8-K](/filings/0001493152-26-023707.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-023707 |
| 2026-05-14 | 08:47 ET | [SCHEDULE 13D/A](/filings/0001753926-26-000869.md) | Ownership report, active investor, amended | 0001753926-26-000869 |
| 2026-04-27 | 16:10 ET | [8-K](/filings/0001493152-26-019133.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-019133 |
| 2026-04-15 | 17:01 ET | [10-K](/filings/0001493152-26-016858.md) | Annual report, period 2025-12-31 | 0001493152-26-016858 |
| 2026-03-30 | 21:21 ET | [SCHEDULE 13D](/filings/0001753926-26-000581.md) | Ownership report, active investor | 0001753926-26-000581 |
| 2026-03-25 | 08:15 ET | [8-K](/filings/0001493152-26-012538.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-012538 |
| 2026-03-18 | 16:53 ET | [8-K](/filings/0001493152-26-011270.md) | 5.07 Shareholder vote results | 0001493152-26-011270 |
| 2026-03-09 | 16:05 ET | [8-K](/filings/0001493152-26-009367.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-009367 |
| 2026-03-06 | 16:12 ET | [DEF 14A](/filings/0001493152-26-009143.md) | Proxy statement, period 2026-03-06 | 0001493152-26-009143 |
| 2026-02-24 | 17:11 ET | [8-K](/filings/0001493152-26-007906.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-007906 |
| 2026-01-22 | 16:15 ET | [8-K](/filings/0001493152-26-003244.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-003244 |
| 2026-01-02 | 16:30 ET | [8-K](/filings/0001493152-26-000143.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-000143 |
| 2025-12-22 | 16:05 ET | [SCHEDULE 13D/A](/filings/0001493152-25-028760.md) | Ownership report, active investor, amended | 0001493152-25-028760 |
| 2025-12-12 | 16:15 ET | [8-K](/filings/0001493152-25-027489.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-027489 |
| 2025-11-13 | 16:46 ET | [10-Q](/filings/0001493152-25-022373.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022373 |
| 2025-10-09 | 08:15 ET | [8-K](/filings/0001493152-25-017533.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-017533 |
| 2025-09-22 | 17:56 ET | [SCHEDULE 13D/A](/filings/0001493152-25-014521.md) | Ownership report, active investor, amended | 0001493152-25-014521 |
| 2025-08-14 | 17:00 ET | [10-Q](/filings/0001641172-25-024140.md) | Quarterly report, period 2025-06-30 | 0001641172-25-024140 |
| 2025-08-14 | 16:55 ET | [10-Q/A](/filings/0001641172-25-024123.md) | Quarterly report, amended, period 2025-03-31 | 0001641172-25-024123 |
| 2025-08-14 | 13:11 ET | [8-K](/filings/0001641172-25-023840.md) | 4.02 Non-reliance on financial statements | 0001641172-25-023840 |
| 2025-08-08 | 16:10 ET | [8-K](/filings/0001641172-25-022760.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-022760 |
| 2025-07-31 | 19:46 ET | [SCHEDULE 13D/A](/filings/0001641172-25-021793.md) | Ownership report, active investor, amended | 0001641172-25-021793 |
| 2025-07-08 | 12:04 ET | [DEF 14A](/filings/0001641172-25-018242.md) | Proxy statement, period 2025-07-08 | 0001641172-25-018242 |
| 2025-06-09 | 16:30 ET | [8-K](/filings/0001641172-25-014322.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-014322 |

Page 1 of 3. [Older](/companies/cdt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:31 ET. No prices; not investment advice.